首页 | 本学科首页   官方微博 | 高级检索  
     

万拉法新治疗注意缺陷障碍的临床分析
引用本文:韩凤金,姜宇河,魏汝俊. 万拉法新治疗注意缺陷障碍的临床分析[J]. 临床精神医学杂志, 2002, 12(2): 78-79
作者姓名:韩凤金  姜宇河  魏汝俊
作者单位:161200,黑龙江齐齐哈尔市第二神经精神病院
摘    要:目的:观察万拉法新治疗注意缺陷障碍(ADHD)的疗效与副反应。方法:前瞻性研究,对33例患者分别以万拉法新与利他林治疗,采用多动指数量表(CIH)及不良反应症状量表(TESS)评定疗效与副反应,治疗4周。结果:两组疗效,减分率差异无显著性,但万拉法新副反应较少而轻,依从性好。结论:万拉法新与利他林的疗效相似,不良反应少,安全有效。

关 键 词:万拉法新 利他林 注意缺陷障碍 治疗
文章编号:1005-3220(2002)02-0078-02
修稿时间:2001-08-20

Clinical analysis of hyperactivity disorder of childhood treated with venlafaxine
Han Fengjin,Jiang Yuhe,Wei Rujun. Clinical analysis of hyperactivity disorder of childhood treated with venlafaxine[J]. Journal of Clinical Psychological Medicine, 2002, 12(2): 78-79
Authors:Han Fengjin  Jiang Yuhe  Wei Rujun
Affiliation:Han Fengjin,Jiang Yuhe,Wei Rujun. The Second Neuropsychiatric Hospital of Qi Qihaer,Heirongjiang 161200
Abstract:Objective:To observe the efficacy and side effects of venlafaxine in the treatment of hyperactivity disorder of childhood. Method:33 patients with hyperactivity disorder of childhood were randomly treated with venlafaxine or ritaline for four weeks. Conners index of hyperactivity (CIH) and the treatment emergent symptom scale (TESS) were used to assess the effect and side effects. Results:There was no significant difference in the therapeutic response between the two groups, but venlafaxine had significantly fewer side effects. Conclusion: Venlafaxine is an effective and safe drug to treat hyperactivity disorder of childhood.
Keywords:Venlafaxine  Ritaline  Hyperactivity disorder of childhood
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号